{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T10:10:30Z","timestamp":1764238230466,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ajps.2022.03.004","type":"journal-article","created":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T07:55:35Z","timestamp":1651305335000},"page":"462-474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Gp350-anchored extracellular vesicles: promising vehicles for delivering therapeutic drugs of B cell malignancies"],"prefix":"10.1016","volume":"17","author":[{"given":"Huiqing","family":"Xiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Nan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danfeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaoli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanmei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guirun","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gensheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunshan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4317-2630","authenticated-orcid":false,"given":"Zhijian","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajps.2022.03.004_bib0001","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/imr.12243","article-title":"Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies","volume":"263","author":"Gill","year":"2015","journal-title":"Immunol Rev"},{"issue":"16","key":"10.1016\/j.ajps.2022.03.004_bib0002","doi-asserted-by":"crossref","first-page":"8996","DOI":"10.3390\/ijms22168996","article-title":"CAR T-cell therapy in hematological malignancies","volume":"22","author":"Haslauer","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"177","key":"10.1016\/j.ajps.2022.03.004_bib0003","doi-asserted-by":"crossref","first-page":"177ra38","DOI":"10.1126\/scitranslmed.3005930","article-title":"CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia","volume":"5","author":"Brentjens","year":"2013","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.ajps.2022.03.004_bib0004","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13045-020-00856-8","article-title":"Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia","volume":"13","author":"Dai","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"8","key":"10.1016\/j.ajps.2022.03.004_bib0005","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1007\/s00262-021-02850-6","article-title":"CAR19\/22 T cell therapy in adult refractory Burkitt's lymphoma","volume":"70","author":"Zhou","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ajps.2022.03.004_bib0006","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3389\/fonc.2020.00849","article-title":"CAR T-cell therapy for B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia: clinical trials and real-world experiences","volume":"10","author":"Vitale","year":"2020","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.ajps.2022.03.004_bib0007","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1182\/blood-2012-09-457531","article-title":"T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production","volume":"121","author":"Riches","year":"2013","journal-title":"BLOOD"},{"issue":"14","key":"10.1016\/j.ajps.2022.03.004_bib0008","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood-2010-03-275446","article-title":"Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia","volume":"116","author":"Zhou","year":"2010","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.ajps.2022.03.004_bib0009","doi-asserted-by":"crossref","first-page":"7652","DOI":"10.3390\/ijms22147652","article-title":"Cytokine release syndrome associated with T-cell-based therapies for hematological malignancies: pathophysiology, clinical presentation, and treatment","volume":"22","author":"Cosenza","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ajps.2022.03.004_bib0010","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s40425-019-0686-x","article-title":"State-of-the-art for CAR T-cell therapy for chronic lymphocytic leukemia in 2019","volume":"7","author":"Lemal","year":"2019","journal-title":"Journal for immunotherapy of cancer"},{"issue":"12","key":"10.1016\/j.ajps.2022.03.004_bib0011","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/s41409-018-0235-0","article-title":"CAR T cells induce a complete response in refractory Burkitt Lymphoma","volume":"53","author":"Avigdor","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ajps.2022.03.004_bib0012","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2019.06.006","article-title":"Systematic review of targeted extracellular vesicles for drug delivery - Considerations on methodological and biological heterogeneity","volume":"306","author":"Gudbergsson","year":"2019","journal-title":"J Control Release"},{"issue":"4","key":"10.1016\/j.ajps.2022.03.004_bib0013","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"van Niel","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"17","key":"10.1016\/j.ajps.2022.03.004_bib0014","first-page":"6097","volume":"21","author":"Sun","year":"2020","journal-title":"Extracellular vesicles in the development of cancer therapeutics"},{"issue":"1","key":"10.1016\/j.ajps.2022.03.004_bib0015","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41392-021-00631-2","article-title":"Recent progress in targeted delivery vectors based on biomimetic nanoparticles","volume":"6","author":"Chen","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"10.1016\/j.ajps.2022.03.004_bib0016","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","article-title":"Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory","volume":"177","author":"Poggio","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ajps.2022.03.004_bib0017","article-title":"Update on Nanoparticle-Based Drug Delivery System for Anti-inflammatory Treatment","volume":"9","author":"Wang","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"issue":"5","key":"10.1016\/j.ajps.2022.03.004_bib0018","doi-asserted-by":"crossref","first-page":"e12076","DOI":"10.1002\/jev2.12076","article-title":"Engineered extracellular vesicles as versatile ribonucleoprotein delivery vehicles for efficient and safe CRISPR genome editing","volume":"10","author":"Yao","year":"2021","journal-title":"J Extracell Vesicles"},{"issue":"7","key":"10.1016\/j.ajps.2022.03.004_bib0019","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.biomaterials.2013.11.083","article-title":"A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy","volume":"35","author":"Tian","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2022.03.004_bib0020","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.addr.2020.04.004","article-title":"Extracellular vesicles as drug delivery systems: Why and how?","volume":"159","author":"Elsharkasy","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.ajps.2022.03.004_bib0021","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41578-020-00277-6","article-title":"Extracellular vesicles versus synthetic nanoparticles for drug delivery","volume":"6","author":"Witwer","year":"2021","journal-title":"Nature Reviews Materials"},{"issue":"7659","key":"10.1016\/j.ajps.2022.03.004_bib0022","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature22341","article-title":"Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer","volume":"546","author":"Kamerkar","year":"2017","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.ajps.2022.03.004_bib0023","doi-asserted-by":"crossref","first-page":"eaaz6980","DOI":"10.1126\/sciadv.aaz6980","article-title":"Exosome-based delivery of super-repressor I\u03baB\u03b1 relieves sepsis-associated organ damage and mortality","volume":"6","author":"Choi","year":"2020","journal-title":"Science Advances"},{"issue":"1","key":"10.1016\/j.ajps.2022.03.004_bib0024","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1038\/s41467-018-04791-8","article-title":"Efficient RNA drug delivery using red blood cell extracellular vesicles","volume":"9","author":"Usman","year":"2018","journal-title":"Nature Communication"},{"issue":"2","key":"10.1016\/j.ajps.2022.03.004_bib0025","doi-asserted-by":"crossref","first-page":"e12030","DOI":"10.1002\/jev2.12030","article-title":"Extracellular vesicles: natural liver-accumulating drug delivery vehicles for the treatment of liver diseases","volume":"10","author":"Zhang","year":"2020","journal-title":"J Extracell Vesicles"},{"issue":"14","key":"10.1016\/j.ajps.2022.03.004_bib0026","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1073\/pnas.81.14.4510","article-title":"Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2","volume":"81","author":"Fingeroth","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.ajps.2022.03.004_bib0027","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4049\/jimmunol.1001145","article-title":"Exosomes containing glycoprotein 350 released by EBV-transformed B cells selectively target B cells through CD21 and block EBV infection in vitro","volume":"186","author":"Vallhov","year":"2011","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.ajps.2022.03.004_bib0028","doi-asserted-by":"crossref","first-page":"e25294","DOI":"10.1371\/journal.pone.0025294","article-title":"EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells\u2013a new option for the treatment of B-CLL","volume":"6","author":"Ruiss","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ajps.2022.03.004_bib0029","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2141.2008.06988.x","article-title":"Recent advances in the understanding and management of diffuse large B-cell lymphoma in children","volume":"142","author":"Reiter","year":"2008","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.ajps.2022.03.004_bib0030","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1586\/14737140.6.9.1141","article-title":"Role of fludarabine in hematological malignancies","volume":"6","author":"Montillo","year":"2006","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"10.1016\/j.ajps.2022.03.004_bib0031","doi-asserted-by":"crossref","first-page":"17159","DOI":"10.1038\/s41598-017-17144-0","article-title":"\u03b2-Sheet structure within the extracellular domain of C99 regulates amyloidogenic processing","volume":"7","author":"Hu","year":"2017","journal-title":"Scientific reports"},{"issue":"11","key":"10.1016\/j.ajps.2022.03.004_bib0032","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/bmc.1054","article-title":"Improved HPLC method for doxorubicin quantification in rat plasma to study the pharmacokinetics of micelle-encapsulated and liposome-encapsulated doxorubicin formulations","volume":"22","author":"Wei","year":"2008","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.ajps.2022.03.004_bib0033","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jchromb.2017.03.024","article-title":"Lefebvre-Tournier I. Determination and quantification of intracellular fludarabine triphosphate, cladribine triphosphate and clofarabine triphosphate by LC-MS\/MS in human cancer cells","volume":"1053","author":"Puy","year":"2017","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"5","key":"10.1016\/j.ajps.2022.03.004_bib0034","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.4049\/jimmunol.1701447","article-title":"CD8alpha(+)CD11c(+) Extracellular vesicles in the lungs control immune homeostasis of the respiratory tract via TGF-beta1 and IL-10","volume":"200","author":"Wan","year":"2018","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.ajps.2022.03.004_bib0035","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00109-006-0154-1","article-title":"Surface anchorage of superantigen SEA promotes induction of specific antitumor immune response by tumor-derived exosomes","volume":"85","author":"Xiu","year":"2007","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.ajps.2022.03.004_bib0036","doi-asserted-by":"crossref","first-page":"e48287","DOI":"10.7554\/eLife.48287","article-title":"Electroporated recombinant proteins as tools for in vivo functional complementation, imaging and chemical biology","volume":"8","author":"Alex","year":"2019","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.ajps.2022.03.004_bib0039","first-page":"302","article-title":"Chronic statin administration may attenuate early anthracycline-associated declines in left ventricular ejection function","volume":"31","author":"Chotenimitkhun","year":"2015","journal-title":"Can J Cardiol"},{"issue":"2","key":"10.1016\/j.ajps.2022.03.004_bib0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1124\/mol.119.115725","article-title":"Ait-Oudhia S. Insights into doxorubicin-induced cardiotoxicity: molecular mechanisms, preventive strategies, and early monitoring","volume":"96","author":"Wenningmann","year":"2019","journal-title":"Mol Pharmacol"},{"issue":"10","key":"10.1016\/j.ajps.2022.03.004_bib0041","doi-asserted-by":"crossref","first-page":"194","DOI":"10.21037\/atm.2016.05.19","article-title":"An historical approach to the diagnostic biomarkers of acute coronary syndrome","volume":"4","author":"Danese","year":"2016","journal-title":"Ann Transl Med"},{"issue":"13","key":"10.1016\/j.ajps.2022.03.004_bib0042","article-title":"Acid-responsive H(2) -releasing 2D MgB(2) nanosheet for therapeutic synergy and side effect attenuation of gastric cancer chemotherapy","volume":"8","author":"Fan","year":"2019","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"10.1016\/j.ajps.2022.03.004_bib0043","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/10717544.2019.1591544","article-title":"Doxorubicin-loaded red blood cells reduced cardiac toxicity and preserved anticancer activity","volume":"26","author":"Lucas","year":"2019","journal-title":"Drug Delivery"},{"issue":"12","key":"10.1016\/j.ajps.2022.03.004_bib0044","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/1873-3468.14091","article-title":"Resveratrol reduces cardiac NLRP3-inflammasome activation and systemic inflammation to lessen doxorubicin-induced cardiotoxicity in juvenile mice","volume":"595","author":"Maayah","year":"2021","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.ajps.2022.03.004_bib0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1470-2045(15)00447-7","article-title":"Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial","volume":"17","author":"Rummel","year":"2016","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.ajps.2022.03.004_bib0046","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.leukres.2006.02.011","article-title":"Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia","volume":"30","author":"Nishida","year":"2006","journal-title":"Leuk Res"},{"issue":"5","key":"10.1016\/j.ajps.2022.03.004_bib0047","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s00277-002-0457-4","article-title":"Fludarabine-induced eosinophilia: case report","volume":"81","author":"Voutsadakis","year":"2002","journal-title":"Ann Hematol"}],"container-title":["Asian Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087622000423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087622000423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:48:41Z","timestamp":1761724121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1818087622000423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1818087622000423"],"URL":"https:\/\/doi.org\/10.1016\/j.ajps.2022.03.004","relation":{},"ISSN":["1818-0876"],"issn-type":[{"type":"print","value":"1818-0876"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gp350-anchored extracellular vesicles: promising vehicles for delivering therapeutic drugs of B cell malignancies","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajps.2022.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Shenyang Pharmaceutical University. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}